[go: up one dir, main page]

DK2137539T3 - Amolorid følsomme calciumkanaler forbundet med paniklidelser - Google Patents

Amolorid følsomme calciumkanaler forbundet med paniklidelser

Info

Publication number
DK2137539T3
DK2137539T3 DK08715633.7T DK08715633T DK2137539T3 DK 2137539 T3 DK2137539 T3 DK 2137539T3 DK 08715633 T DK08715633 T DK 08715633T DK 2137539 T3 DK2137539 T3 DK 2137539T3
Authority
DK
Denmark
Prior art keywords
panic disorder
polymorphisms
amoloride
calcium channels
channels associated
Prior art date
Application number
DK08715633.7T
Other languages
English (en)
Inventor
Hans Atli Dahl
August G Wang
Torben Kruse
Maria Vang
Ole Mors
Original Assignee
Ilegusavnid Genetics Resource Ct Minestry Of Social Affairs And Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilegusavnid Genetics Resource Ct Minestry Of Social Affairs And Health filed Critical Ilegusavnid Genetics Resource Ct Minestry Of Social Affairs And Health
Application granted granted Critical
Publication of DK2137539T3 publication Critical patent/DK2137539T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/301Anxiety or phobic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Credit Cards Or The Like (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK08715633.7T 2007-04-03 2008-04-03 Amolorid følsomme calciumkanaler forbundet med paniklidelser DK2137539T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200700519 2007-04-03
PCT/DK2008/050080 WO2008119360A1 (en) 2007-04-03 2008-04-03 Amiloride sensitive sodium channels associated with panic disorders

Publications (1)

Publication Number Publication Date
DK2137539T3 true DK2137539T3 (da) 2011-01-24

Family

ID=38312417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08715633.7T DK2137539T3 (da) 2007-04-03 2008-04-03 Amolorid følsomme calciumkanaler forbundet med paniklidelser

Country Status (5)

Country Link
EP (1) EP2137539B1 (da)
AT (1) ATE483985T1 (da)
DE (1) DE602008002913D1 (da)
DK (1) DK2137539T3 (da)
WO (1) WO2008119360A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9371383B2 (en) 2012-01-31 2016-06-21 Regeneron Pharmaceuticals, Inc. Anti-ASIC1 antibodies and uses thereof
HUE042531T2 (hu) 2012-01-31 2019-07-29 Regeneron Pharma ASIC1-ellenes antitestek és alkalmazásaik

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304494A1 (en) * 2000-04-20 2001-10-20 Philippe Seguela A novel heteromultimeric ion channel receptor and uses thereof
US20030186860A1 (en) * 2002-03-29 2003-10-02 Welsh Michael J. Novel compositions and methods for modulating the acid-sensing ion channel (ASIC)

Also Published As

Publication number Publication date
WO2008119360A1 (en) 2008-10-09
DE602008002913D1 (de) 2010-11-18
EP2137539B1 (en) 2010-10-06
ATE483985T1 (de) 2010-10-15
EP2137539A1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
EA200702048A1 (ru) Фармакокинетически улучшенные соединения
PH12018500045A1 (en) Compositions and methods for treating and diagnosing asthma
MX2007014616A (es) Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos.
CY1117546T1 (el) Eνωση διαμινο ετεροκυκλικου καρβοξαμιδιου
EA201270184A1 (ru) Лечение расстройств печени ингибиторами pi3k
EA200702203A1 (ru) Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений
BRPI0513982A (pt) inibidores de sinalização de receptor de vegf e receptor de hgf
ATE446094T1 (de) Mitotische kinesin-hemmer
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
IN2012DN02485A (da)
MY148468A (en) Compounds and methods for kinase modulation, and indications therefor
MX2009006688A (es) Compuestos y metodos para modulacion de cinasas, e indicaciones para ello.
WO2010036960A8 (en) Methods for treating, diagnosing, and monitoring lupus
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
ATE461923T1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
WO2008106594A3 (en) Inhibitors of nucleophosmin (npm) and methods for inducing apoptosis
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
ATE540036T1 (de) Heterocyclische derivate als ionenkanalmodulatoren
WO2009073575A3 (en) Methods for treating induced cellular proliferative disorders
DE602005001192D1 (de) Zusammensetzung und Verfahren zur Verbesserung der Wärmestabilität und der Witterungsstabilität von segementierten Polyurethanpolymeren
DK2137539T3 (da) Amolorid følsomme calciumkanaler forbundet med paniklidelser
PT1529116E (pt) Métodos para o tratamento da demência com base no genótipo da apo e
MX2012001999A (es) Uso de inhibidores nkg2d para tratar enfermedades cardiovasculares y metabolicas, tal como diabetes tipo 2.